https://www.selleckchem.com/GSK-3.html
Higher percentages of PD-1 T cells were observed following SBRT, and a subset of tumors displayed more clonal T-cell repertoires. These findings suggest that SBRT augmentation of antitumor immunogenicity may be dampened by an overabundance of refractory immunosuppressive populations, and support the continued development of SBRT/immunotherapy combination for human PDAC. These findings suggest that SBRT augmentation of antitumor immunogenicity may be dampened by an overabundance of refractory immunosuppressive populations, and support the continued
Like
Comment
Share
